Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

DMK Pharmaceuticals Q3 EPS $(0.20) Up From $(2.05) YoY, Sales $9.06K Down From $1.51M YoY

Author: Benzinga Newsdesk | November 14, 2023 08:35am
DMK Pharmaceuticals (NASDAQ:DMK) reported quarterly losses of $(0.20) per share. This is a 90.24 percent increase over losses of $(2.05) per share from the same period last year. The company reported $9.06 thousand in sales this quarter. This is a 99.40 percent decrease over sales of $1.51 million the same period last year.

Posted In: DMK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist